APO Research
Talk to an analyst

APO RESEARCH · REPORT

Adult Preventable Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Adult Preventable Vaccines Market Analysis and Forecast 2026-2032

26 December 2025195 pages

Choose your research edition.

Industry ResearchAdult Preventable Vaccines Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Adult Preventable Vaccines Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Adult Preventable Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adult Preventable Vaccines Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Adult Preventable Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Adult Preventable Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Adult Preventable Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Adult Preventable Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Adult Preventable Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Adult Preventable Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Adult Preventable Vaccines include Sanofi Pasteur, Johnson & Johnson (Janssen), Pfizer Inc., GlaxoSmithKline plc (GSK), Sinovac Biotech, Sinopharm Group Co.,, Serum Institute of India Pvt., Novavax, Inc. and Moderna, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Adult Preventable Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Adult Preventable Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Adult Preventable Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Adult Preventable Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Adult Preventable Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Adult Preventable Vaccines sales, projected growth trends, production technology, application and end-user industry.

Adult Preventable Vaccines Segment by Company

Sanofi Pasteur

Johnson & Johnson (Janssen)

Pfizer Inc.

GlaxoSmithKline plc (GSK)

Sinovac Biotech

Sinopharm Group Co.,

Serum Institute of India Pvt.

Novavax, Inc.

Moderna, Inc.

Merck & Co., Inc.

Emergent BioSolutions Inc.

Daiichi Sankyo Company

CSL Limited (Seqirus)

Bharat Biotech International

AstraZeneca plc

Adult Preventable Vaccines Segment by Type

Viral Vector Vaccines

Peptide Vaccines

Inactivated Vaccines

Subunit Vaccines

Mrna Vaccines

Adult Preventable Vaccines Segment by Application

Prevent Herpes Zoster

Prevent Pneumococcal Infection

Prevent Influenza

Prevent Human Papillomavirus (Hpv)

Prevent Hepatitis B

Other

Adult Preventable Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult Preventable Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adult Preventable Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult Preventable Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Adult Preventable Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Adult Preventable Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adult Preventable Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Adult Preventable Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Viral Vector Vaccines Major Manufacturers Table 3. Peptide Vaccines Major Manufacturers Table 4. Inactivated Vaccines Major Manufacturers Table 5. Subunit Vaccines Major Manufacturers Table 6. Mrna Vaccines Major Manufacturers Table 7. Global Adult Preventable Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Prevent Herpes Zoster Major Manufacturers Table 9. Prevent Pneumococcal Infection Major Manufacturers Table 10. Prevent Influenza Major Manufacturers Table 11. Prevent Human Papillomavirus (Hpv) Major Manufacturers Table 12. Prevent Hepatitis B Major Manufacturers Table 13. Other Major Manufacturers Table 14. Adult Preventable Vaccines Industry Trends Table 15. Adult Preventable Vaccines Industry Drivers Table 16. Adult Preventable Vaccines Industry Opportunities and Challenges Table 17. Adult Preventable Vaccines Industry Restraints Table 18. Global Adult Preventable Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Adult Preventable Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Adult Preventable Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Adult Preventable Vaccines Revenue Market Share by Region (2021-2026) Table 22. Global Adult Preventable Vaccines Revenue Market Share by Region (2027-2032) Table 23. Global Adult Preventable Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 24. Global Adult Preventable Vaccines Sales by Region (2021-2026) & (K Units) Table 25. Global Adult Preventable Vaccines Sales by Region (2027-2032) & (K Units) Table 26. Global Adult Preventable Vaccines Sales Market Share by Region (2021-2026) Table 27. Global Adult Preventable Vaccines Sales Market Share by Region (2027-2032) Table 28. Global Adult Preventable Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Adult Preventable Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Adult Preventable Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Adult Preventable Vaccines Sales Market Share by Manufacturers (2021-2026) Table 32. Global Adult Preventable Vaccines Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 33. Global Adult Preventable Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Adult Preventable Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Adult Preventable Vaccines Manufacturers, Product Type & Application Table 36. Global Adult Preventable Vaccines Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Adult Preventable Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Adult Preventable Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Adult Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Adult Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Adult Preventable Vaccines Revenue Market Share by Type (2021-2026) Table 43. Global Adult Preventable Vaccines Revenue Market Share by Type (2027-2032) Table 44. Global Adult Preventable Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 45. Global Adult Preventable Vaccines Sales by Type (2021-2026) & (K Units) Table 46. Global Adult Preventable Vaccines Sales by Type (2027-2032) & (K Units) Table 47. Global Adult Preventable Vaccines Sales Market Share by Type (2021-2026) Table 48. Global Adult Preventable Vaccines Sales Market Share by Type (2027-2032) Table 49. Global Adult Preventable Vaccines Price by Type (2021-2026) & (US$/Unit) Table 50. Global Adult Preventable Vaccines Price by Type (2027-2032) & (US$/Unit) Table 51. Global Adult Preventable Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Adult Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Adult Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Adult Preventable Vaccines Revenue Market Share by Application (2021-2026) Table 55. Global Adult Preventable Vaccines Revenue Market Share by Application (2027-2032) Table 56. Global Adult Preventable Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 57. Global Adult Preventable Vaccines Sales by Application (2021-2026) & (K Units) Table 58. Global Adult Preventable Vaccines Sales by Application (2027-2032) & (K Units) Table 59. Global Adult Preventable Vaccines Sales Market Share by Application (2021-2026) Table 60. Global Adult Preventable Vaccines Sales Market Share by Application (2027-2032) Table 61. Global Adult Preventable Vaccines Price by Application (2021-2026) & (US$/Unit) Table 62. Global Adult Preventable Vaccines Price by Application (2027-2032) & (US$/Unit) Table 63. Sanofi Pasteur Company Information Table 64. Sanofi Pasteur Business Overview Table 65. Sanofi Pasteur Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sanofi Pasteur Adult Preventable Vaccines Product Portfolio Table 67. Sanofi Pasteur Recent Development Table 68. Johnson & Johnson (Janssen) Company Information Table 69. Johnson & Johnson (Janssen) Business Overview Table 70. Johnson & Johnson (Janssen) Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Johnson & Johnson (Janssen) Adult Preventable Vaccines Product Portfolio Table 72. Johnson & Johnson (Janssen) Recent Development Table 73. Pfizer Inc. Company Information Table 74. Pfizer Inc. Business Overview Table 75. Pfizer Inc. Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Pfizer Inc. Adult Preventable Vaccines Product Portfolio Table 77. Pfizer Inc. Recent Development Table 78. GlaxoSmithKline plc (GSK) Company Information Table 79. GlaxoSmithKline plc (GSK) Business Overview Table 80. GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Product Portfolio Table 82. GlaxoSmithKline plc (GSK) Recent Development Table 83. Sinovac Biotech Company Information Table 84. Sinovac Biotech Business Overview Table 85. Sinovac Biotech Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sinovac Biotech Adult Preventable Vaccines Product Portfolio Table 87. Sinovac Biotech Recent Development Table 88. Sinopharm Group Co., Company Information Table 89. Sinopharm Group Co., Business Overview Table 90. Sinopharm Group Co., Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sinopharm Group Co., Adult Preventable Vaccines Product Portfolio Table 92. Sinopharm Group Co., Recent Development Table 93. Serum Institute of India Pvt. Company Information Table 94. Serum Institute of India Pvt. Business Overview Table 95. Serum Institute of India Pvt. Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Serum Institute of India Pvt. Adult Preventable Vaccines Product Portfolio Table 97. Serum Institute of India Pvt. Recent Development Table 98. Novavax, Inc. Company Information Table 99. Novavax, Inc. Business Overview Table 100. Novavax, Inc. Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Novavax, Inc. Adult Preventable Vaccines Product Portfolio Table 102. Novavax, Inc. Recent Development Table 103. Moderna, Inc. Company Information Table 104. Moderna, Inc. Business Overview Table 105. Moderna, Inc. Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Moderna, Inc. Adult Preventable Vaccines Product Portfolio Table 107. Moderna, Inc. Recent Development Table 108. Merck & Co., Inc. Company Information Table 109. Merck & Co., Inc. Business Overview Table 110. Merck & Co., Inc. Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Merck & Co., Inc. Adult Preventable Vaccines Product Portfolio Table 112. Merck & Co., Inc. Recent Development Table 113. Emergent BioSolutions Inc. Company Information Table 114. Emergent BioSolutions Inc. Business Overview Table 115. Emergent BioSolutions Inc. Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Emergent BioSolutions Inc. Adult Preventable Vaccines Product Portfolio Table 117. Emergent BioSolutions Inc. Recent Development Table 118. Daiichi Sankyo Company Company Information Table 119. Daiichi Sankyo Company Business Overview Table 120. Daiichi Sankyo Company Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Daiichi Sankyo Company Adult Preventable Vaccines Product Portfolio Table 122. Daiichi Sankyo Company Recent Development Table 123. CSL Limited (Seqirus) Company Information Table 124. CSL Limited (Seqirus) Business Overview Table 125. CSL Limited (Seqirus) Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. CSL Limited (Seqirus) Adult Preventable Vaccines Product Portfolio Table 127. CSL Limited (Seqirus) Recent Development Table 128. Bharat Biotech International Company Information Table 129. Bharat Biotech International Business Overview Table 130. Bharat Biotech International Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Bharat Biotech International Adult Preventable Vaccines Product Portfolio Table 132. Bharat Biotech International Recent Development Table 133. AstraZeneca plc Company Information Table 134. AstraZeneca plc Business Overview Table 135. AstraZeneca plc Adult Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. AstraZeneca plc Adult Preventable Vaccines Product Portfolio Table 137. AstraZeneca plc Recent Development Table 138. North America Adult Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 139. North America Adult Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 140. North America Adult Preventable Vaccines Sales by Type (2021-2026) & (K Units) Table 141. North America Adult Preventable Vaccines Sales by Type (2027-2032) & (K Units) Table 142. North America Adult Preventable Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 143. North America Adult Preventable Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 144. North America Adult Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 145. North America Adult Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 146. North America Adult Preventable Vaccines Sales by Application (2021-2026) & (K Units) Table 147. North America Adult Preventable Vaccines Sales by Application (2027-2032) & (K Units) Table 148. North America Adult Preventable Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 149. North America Adult Preventable Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 150. North America Adult Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. North America Adult Preventable Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. North America Adult Preventable Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. North America Adult Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 154. North America Adult Preventable Vaccines Sales by Country (2021-2026) & (K Units) Table 155. North America Adult Preventable Vaccines Sales by Country (2027-2032) & (K Units) Table 156. North America Adult Preventable Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 157. North America Adult Preventable Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 158. United States Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 159. Canada Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 160. Mexico Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 161. Europe Adult Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 162. Europe Adult Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 163. Europe Adult Preventable Vaccines Sales by Type (2021-2026) & (K Units) Table 164. Europe Adult Preventable Vaccines Sales by Type (2027-2032) & (K Units) Table 165. Europe Adult Preventable Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 166. Europe Adult Preventable Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 167. Europe Adult Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe Adult Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe Adult Preventable Vaccines Sales by Application (2021-2026) & (K Units) Table 170. Europe Adult Preventable Vaccines Sales by Application (2027-2032) & (K Units) Table 171. Europe Adult Preventable Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 172. Europe Adult Preventable Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 173. Europe Adult Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Europe Adult Preventable Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Europe Adult Preventable Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Europe Adult Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 177. Europe Adult Preventable Vaccines Sales by Country (2021-2026) & (K Units) Table 178. Europe Adult Preventable Vaccines Sales by Country (2027-2032) & (K Units) Table 179. Europe Adult Preventable Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 180. Europe Adult Preventable Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Germany Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 182. France Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 183. U.K. Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 184. Italy Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 185. Russia Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 186. Spain Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 187. Netherlands Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 188. Switzerland Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 189. Sweden Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 190. Poland Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 191. China Adult Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 192. China Adult Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 193. China Adult Preventable Vaccines Sales by Type (2021-2026) & (K Units) Table 194. China Adult Preventable Vaccines Sales by Type (2027-2032) & (K Units) Table 195. China Adult Preventable Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 196. China Adult Preventable Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 197. China Adult Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 198. China Adult Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 199. China Adult Preventable Vaccines Sales by Application (2021-2026) & (K Units) Table 200. China Adult Preventable Vaccines Sales by Application (2027-2032) & (K Units) Table 201. China Adult Preventable Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 202. China Adult Preventable Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 203. Asia Adult Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 204. Asia Adult Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 205. Asia Adult Preventable Vaccines Sales by Type (2021-2026) & (K Units) Table 206. Asia Adult Preventable Vaccines Sales by Type (2027-2032) & (K Units) Table 207. Asia Adult Preventable Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 208. Asia Adult Preventable Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 209. Asia Adult Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 210. Asia Adult Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 211. Asia Adult Preventable Vaccines Sales by Application (2021-2026) & (K Units) Table 212. Asia Adult Preventable Vaccines Sales by Application (2027-2032) & (K Units) Table 213. Asia Adult Preventable Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 214. Asia Adult Preventable Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 215. Asia Adult Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. Asia Adult Preventable Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. Asia Adult Preventable Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. Asia Adult Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 219. Asia Adult Preventable Vaccines Sales by Country (2021-2026) & (K Units) Table 220. Asia Adult Preventable Vaccines Sales by Country (2027-2032) & (K Units) Table 221. Asia Adult Preventable Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 222. Asia Adult Preventable Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 223. Japan Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 224. South Korea Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 225. India Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 226. Australia Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 227. Taiwan Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 228. Southeast Asia Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 229. SAMEA Adult Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 230. SAMEA Adult Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 231. SAMEA Adult Preventable Vaccines Sales by Type (2021-2026) & (K Units) Table 232. SAMEA Adult Preventable Vaccines Sales by Type (2027-2032) & (K Units) Table 233. SAMEA Adult Preventable Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 234. SAMEA Adult Preventable Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 235. SAMEA Adult Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 236. SAMEA Adult Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 237. SAMEA Adult Preventable Vaccines Sales by Application (2021-2026) & (K Units) Table 238. SAMEA Adult Preventable Vaccines Sales by Application (2027-2032) & (K Units) Table 239. SAMEA Adult Preventable Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 240. SAMEA Adult Preventable Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 241. SAMEA Adult Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 242. SAMEA Adult Preventable Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 243. SAMEA Adult Preventable Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 244. SAMEA Adult Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 245. SAMEA Adult Preventable Vaccines Sales by Country (2021-2026) & (K Units) Table 246. SAMEA Adult Preventable Vaccines Sales by Country (2027-2032) & (K Units) Table 247. SAMEA Adult Preventable Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 248. SAMEA Adult Preventable Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 249. Brazil Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 250. Argentina Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 251. Chile Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 252. Colombia Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 253. Peru Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 254. Saudi Arabia Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 255. Israel Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 256. UAE Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 257. Turkey Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 258. Iran Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 259. Egypt Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 260. Key Raw Materials Table 261. Raw Materials Key Suppliers Table 262. Adult Preventable Vaccines Distributors List Table 263. Adult Preventable Vaccines Customers List Table 264. Research Programs/Design for This Report Table 265. Authors List of This Report Table 266. Secondary Sources Table 267. Primary Sources List of Figures Figure 1. Adult Preventable Vaccines Image Figure 2. Global Adult Preventable Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adult Preventable Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Viral Vector Vaccines Image Figure 5. Peptide Vaccines Image Figure 6. Inactivated Vaccines Image Figure 7. Subunit Vaccines Image Figure 8. Mrna Vaccines Image Figure 9. Global Adult Preventable Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Adult Preventable Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 11. Prevent Herpes Zoster Image Figure 12. Prevent Pneumococcal Infection Image Figure 13. Prevent Influenza Image Figure 14. Prevent Human Papillomavirus (Hpv) Image Figure 15. Prevent Hepatitis B Image Figure 16. Other Image Figure 17. Global Adult Preventable Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Adult Preventable Vaccines Revenue (2021-2032) & (US$ Million) Figure 19. Global Adult Preventable Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Adult Preventable Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Adult Preventable Vaccines Revenue Market Share by Region (2021-2032) Figure 22. Global Adult Preventable Vaccines Sales (2021-2032) & (K Units) Figure 23. Global Adult Preventable Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 24. Global Adult Preventable Vaccines Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Adult Preventable Vaccines Sales YoY (2021-2032) & (K Units) Figure 26. Europe Adult Preventable Vaccines Sales YoY (2021-2032) & (K Units) Figure 27. China Adult Preventable Vaccines Sales YoY (2021-2032) & (K Units) Figure 28. Asia (Excluding China) Adult Preventable Vaccines Sales YoY (2021-2032) & (K Units) Figure 29. South America, Middle East and Africa Adult Preventable Vaccines Sales YoY (2021-2032) & (K Units) Figure 30. Global Adult Preventable Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Adult Preventable Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Adult Preventable Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Adult Preventable Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Adult Preventable Vaccines Revenue Market Share by Type (2021-2032) Figure 36. Global Adult Preventable Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Adult Preventable Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Adult Preventable Vaccines Sales Market Share by Type (2021-2032) Figure 39. Global Adult Preventable Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Adult Preventable Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Adult Preventable Vaccines Revenue Market Share by Application (2021-2032) Figure 42. Global Adult Preventable Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 43. Global Adult Preventable Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Adult Preventable Vaccines Sales Market Share by Application (2021-2032) Figure 45. North America Adult Preventable Vaccines Revenue Share by Type (2021-2032) Figure 46. North America Adult Preventable Vaccines Sales Share by Type (2021-2032) Figure 47. North America Adult Preventable Vaccines Revenue Share by Application (2021-2032) Figure 48. North America Adult Preventable Vaccines Sales Share by Application (2021-2032) Figure 49. North America Adult Preventable Vaccines Revenue Share by Country (2021-2032) Figure 50. North America Adult Preventable Vaccines Sales Share by Country (2021-2032) Figure 51. Europe Adult Preventable Vaccines Revenue Share by Type (2021-2032) Figure 52. Europe Adult Preventable Vaccines Sales Share by Type (2021-2032) Figure 53. Europe Adult Preventable Vaccines Revenue Share by Application (2021-2032) Figure 54. Europe Adult Preventable Vaccines Sales Share by Application (2021-2032) Figure 55. Europe Adult Preventable Vaccines Revenue Share by Country (2021-2032) Figure 56. Europe Adult Preventable Vaccines Sales Share by Country (2021-2032) Figure 57. China Adult Preventable Vaccines Revenue Share by Type (2021-2032) Figure 58. China Adult Preventable Vaccines Sales Share by Type (2021-2032) Figure 59. China Adult Preventable Vaccines Revenue Share by Application (2021-2032) Figure 60. China Adult Preventable Vaccines Sales Share by Application (2021-2032) Figure 61. Asia Adult Preventable Vaccines Revenue Share by Type (2021-2032) Figure 62. Asia Adult Preventable Vaccines Sales Share by Type (2021-2032) Figure 63. Asia Adult Preventable Vaccines Revenue Share by Application (2021-2032) Figure 64. Asia Adult Preventable Vaccines Sales Share by Application (2021-2032) Figure 65. Asia Adult Preventable Vaccines Revenue Share by Country (2021-2032) Figure 66. Asia Adult Preventable Vaccines Sales Share by Country (2021-2032) Figure 67. SAMEA Adult Preventable Vaccines Revenue Share by Type (2021-2032) Figure 68. SAMEA Adult Preventable Vaccines Sales Share by Type (2021-2032) Figure 69. SAMEA Adult Preventable Vaccines Revenue Share by Application (2021-2032) Figure 70. SAMEA Adult Preventable Vaccines Sales Share by Application (2021-2032) Figure 71. SAMEA Adult Preventable Vaccines Revenue Share by Country (2021-2032) Figure 72. SAMEA Adult Preventable Vaccines Sales Share by Country (2021-2032) Figure 73. Adult Preventable Vaccines Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Adult Preventable Vaccines Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Viral Vector Vaccines
  • Peptide Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Mrna Vaccines
Applications
  • Prevent Herpes Zoster
  • Prevent Pneumococcal Infection
  • Prevent Influenza
  • Prevent Human Papillomavirus (Hpv)
  • Prevent Hepatitis B
  • Other
Companies covered
  • Sanofi Pasteur
  • Johnson & Johnson (Janssen)
  • Pfizer Inc.
  • GlaxoSmithKline plc (GSK)
  • Sinovac Biotech
  • Sinopharm Group Co.,
  • Serum Institute of India Pvt.
  • Novavax, Inc.
  • Moderna, Inc.
  • Merck & Co., Inc.
  • Emergent BioSolutions Inc.
  • Daiichi Sankyo Company
  • CSL Limited (Seqirus)
  • Bharat Biotech International
  • AstraZeneca plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Adult Preventable Vaccines Market by Type
  3. 1.2.1 Global Adult Preventable Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Viral Vector Vaccines
  5. 1.2.3 Peptide Vaccines
  6. 1.2.4 Inactivated Vaccines
  7. 1.2.5 Subunit Vaccines
  8. 1.2.6 Mrna Vaccines
  9. 1.3 Adult Preventable Vaccines Market by Application
  10. 1.3.1 Global Adult Preventable Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Prevent Herpes Zoster
  12. 1.3.3 Prevent Pneumococcal Infection
  13. 1.3.4 Prevent Influenza
  14. 1.3.5 Prevent Human Papillomavirus (Hpv)
  15. 1.3.6 Prevent Hepatitis B
  16. 1.3.7 Other
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Adult Preventable Vaccines Market Dynamics
  1. 2.1 Adult Preventable Vaccines Industry Trends
  2. 2.2 Adult Preventable Vaccines Industry Drivers
  3. 2.3 Adult Preventable Vaccines Industry Opportunities and Challenges
  4. 2.4 Adult Preventable Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Adult Preventable Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Adult Preventable Vaccines Revenue by Region
  3. 3.2.1 Global Adult Preventable Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Adult Preventable Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Adult Preventable Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Adult Preventable Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Adult Preventable Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Adult Preventable Vaccines Sales by Region
  9. 3.4.1 Global Adult Preventable Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Adult Preventable Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Adult Preventable Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Adult Preventable Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Adult Preventable Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Adult Preventable Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Adult Preventable Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Adult Preventable Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Adult Preventable Vaccines Sales by Manufacturers
  6. 4.2.1 Global Adult Preventable Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Adult Preventable Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Adult Preventable Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Adult Preventable Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Adult Preventable Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Adult Preventable Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Adult Preventable Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Adult Preventable Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Adult Preventable Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Adult Preventable Vaccines Tier 1, Tier 2, and Tier 3
5 Adult Preventable Vaccines Market by Type
  1. 5.1 Global Adult Preventable Vaccines Revenue by Type
  2. 5.1.1 Global Adult Preventable Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Adult Preventable Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Adult Preventable Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Adult Preventable Vaccines Sales by Type
  6. 5.2.1 Global Adult Preventable Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Adult Preventable Vaccines Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Adult Preventable Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Adult Preventable Vaccines Price by Type
6 Adult Preventable Vaccines Market by Application
  1. 6.1 Global Adult Preventable Vaccines Revenue by Application
  2. 6.1.1 Global Adult Preventable Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Adult Preventable Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Adult Preventable Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Adult Preventable Vaccines Sales by Application
  6. 6.2.1 Global Adult Preventable Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Adult Preventable Vaccines Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Adult Preventable Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Adult Preventable Vaccines Price by Application
7 Company Profiles
  1. 7.1 Sanofi Pasteur
  2. 7.1.1 Sanofi Pasteur Company Information
  3. 7.1.2 Sanofi Pasteur Business Overview
  4. 7.1.3 Sanofi Pasteur Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Pasteur Adult Preventable Vaccines Product Portfolio
  6. 7.1.5 Sanofi Pasteur Recent Developments
  7. 7.2 Johnson & Johnson (Janssen)
  8. 7.2.1 Johnson & Johnson (Janssen) Company Information
  9. 7.2.2 Johnson & Johnson (Janssen) Business Overview
  10. 7.2.3 Johnson & Johnson (Janssen) Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson (Janssen) Adult Preventable Vaccines Product Portfolio
  12. 7.2.5 Johnson & Johnson (Janssen) Recent Developments
  13. 7.3 Pfizer Inc.
  14. 7.3.1 Pfizer Inc. Company Information
  15. 7.3.2 Pfizer Inc. Business Overview
  16. 7.3.3 Pfizer Inc. Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Inc. Adult Preventable Vaccines Product Portfolio
  18. 7.3.5 Pfizer Inc. Recent Developments
  19. 7.4 GlaxoSmithKline plc (GSK)
  20. 7.4.1 GlaxoSmithKline plc (GSK) Company Information
  21. 7.4.2 GlaxoSmithKline plc (GSK) Business Overview
  22. 7.4.3 GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Product Portfolio
  24. 7.4.5 GlaxoSmithKline plc (GSK) Recent Developments
  25. 7.5 Sinovac Biotech
  26. 7.5.1 Sinovac Biotech Company Information
  27. 7.5.2 Sinovac Biotech Business Overview
  28. 7.5.3 Sinovac Biotech Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sinovac Biotech Adult Preventable Vaccines Product Portfolio
  30. 7.5.5 Sinovac Biotech Recent Developments
  31. 7.6 Sinopharm Group Co.,
  32. 7.6.1 Sinopharm Group Co., Company Information
  33. 7.6.2 Sinopharm Group Co., Business Overview
  34. 7.6.3 Sinopharm Group Co., Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sinopharm Group Co., Adult Preventable Vaccines Product Portfolio
  36. 7.6.5 Sinopharm Group Co., Recent Developments
  37. 7.7 Serum Institute of India Pvt.
  38. 7.7.1 Serum Institute of India Pvt. Company Information
  39. 7.7.2 Serum Institute of India Pvt. Business Overview
  40. 7.7.3 Serum Institute of India Pvt. Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Serum Institute of India Pvt. Adult Preventable Vaccines Product Portfolio
  42. 7.7.5 Serum Institute of India Pvt. Recent Developments
  43. 7.8 Novavax, Inc.
  44. 7.8.1 Novavax, Inc. Company Information
  45. 7.8.2 Novavax, Inc. Business Overview
  46. 7.8.3 Novavax, Inc. Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Novavax, Inc. Adult Preventable Vaccines Product Portfolio
  48. 7.8.5 Novavax, Inc. Recent Developments
  49. 7.9 Moderna, Inc.
  50. 7.9.1 Moderna, Inc. Company Information
  51. 7.9.2 Moderna, Inc. Business Overview
  52. 7.9.3 Moderna, Inc. Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Moderna, Inc. Adult Preventable Vaccines Product Portfolio
  54. 7.9.5 Moderna, Inc. Recent Developments
  55. 7.10 Merck & Co., Inc.
  56. 7.10.1 Merck & Co., Inc. Company Information
  57. 7.10.2 Merck & Co., Inc. Business Overview
  58. 7.10.3 Merck & Co., Inc. Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Merck & Co., Inc. Adult Preventable Vaccines Product Portfolio
  60. 7.10.5 Merck & Co., Inc. Recent Developments
  61. 7.11 Emergent BioSolutions Inc.
  62. 7.11.1 Emergent BioSolutions Inc. Company Information
  63. 7.11.2 Emergent BioSolutions Inc. Business Overview
  64. 7.11.3 Emergent BioSolutions Inc. Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Emergent BioSolutions Inc. Adult Preventable Vaccines Product Portfolio
  66. 7.11.5 Emergent BioSolutions Inc. Recent Developments
  67. 7.12 Daiichi Sankyo Company
  68. 7.12.1 Daiichi Sankyo Company Company Information
  69. 7.12.2 Daiichi Sankyo Company Business Overview
  70. 7.12.3 Daiichi Sankyo Company Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Daiichi Sankyo Company Adult Preventable Vaccines Product Portfolio
  72. 7.12.5 Daiichi Sankyo Company Recent Developments
  73. 7.13 CSL Limited (Seqirus)
  74. 7.13.1 CSL Limited (Seqirus) Company Information
  75. 7.13.2 CSL Limited (Seqirus) Business Overview
  76. 7.13.3 CSL Limited (Seqirus) Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 CSL Limited (Seqirus) Adult Preventable Vaccines Product Portfolio
  78. 7.13.5 CSL Limited (Seqirus) Recent Developments
  79. 7.14 Bharat Biotech International
  80. 7.14.1 Bharat Biotech International Company Information
  81. 7.14.2 Bharat Biotech International Business Overview
  82. 7.14.3 Bharat Biotech International Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bharat Biotech International Adult Preventable Vaccines Product Portfolio
  84. 7.14.5 Bharat Biotech International Recent Developments
  85. 7.15 AstraZeneca plc
  86. 7.15.1 AstraZeneca plc Company Information
  87. 7.15.2 AstraZeneca plc Business Overview
  88. 7.15.3 AstraZeneca plc Adult Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 AstraZeneca plc Adult Preventable Vaccines Product Portfolio
  90. 7.15.5 AstraZeneca plc Recent Developments
8 North America
  1. 8.1 North America Adult Preventable Vaccines Market Size by Type
  2. 8.1.1 North America Adult Preventable Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Adult Preventable Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Adult Preventable Vaccines Price by Type (2021-2032)
  5. 8.2 North America Adult Preventable Vaccines Market Size by Application
  6. 8.2.1 North America Adult Preventable Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Adult Preventable Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Adult Preventable Vaccines Price by Application (2021-2032)
  9. 8.3 North America Adult Preventable Vaccines Market Size by Country
  10. 8.3.1 North America Adult Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Adult Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Adult Preventable Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Adult Preventable Vaccines Market Size by Type
  2. 9.1.1 Europe Adult Preventable Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Adult Preventable Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Adult Preventable Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Adult Preventable Vaccines Market Size by Application
  6. 9.2.1 Europe Adult Preventable Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Adult Preventable Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Adult Preventable Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Adult Preventable Vaccines Market Size by Country
  10. 9.3.1 Europe Adult Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Adult Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Adult Preventable Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Adult Preventable Vaccines Market Size by Type
  2. 10.1.1 China Adult Preventable Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Adult Preventable Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Adult Preventable Vaccines Price by Type (2021-2032)
  5. 10.2 China Adult Preventable Vaccines Market Size by Application
  6. 10.2.1 China Adult Preventable Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Adult Preventable Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Adult Preventable Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Adult Preventable Vaccines Market Size by Type
  2. 11.1.1 Asia Adult Preventable Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Adult Preventable Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Adult Preventable Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Adult Preventable Vaccines Market Size by Application
  6. 11.2.1 Asia Adult Preventable Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Adult Preventable Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Adult Preventable Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Adult Preventable Vaccines Market Size by Country
  10. 11.3.1 Asia Adult Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Adult Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Adult Preventable Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Adult Preventable Vaccines Market Size by Type
  2. 12.1.1 SAMEA Adult Preventable Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Adult Preventable Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Adult Preventable Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Adult Preventable Vaccines Market Size by Application
  6. 12.2.1 SAMEA Adult Preventable Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Adult Preventable Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Adult Preventable Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Adult Preventable Vaccines Market Size by Country
  10. 12.3.1 SAMEA Adult Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Adult Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Adult Preventable Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Adult Preventable Vaccines Value Chain Analysis
  2. 13.1.1 Adult Preventable Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Adult Preventable Vaccines Production Mode & Process
  6. 13.2 Adult Preventable Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Adult Preventable Vaccines Distributors
  9. 13.2.3 Adult Preventable Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst